Popular Pre-Market Trades in U.S. Stocks
Rigetti Computing's stock price rose by 3.90% in pre-market trading. The rapid development in the field of quantum computing may be a factor driving Rigetti Computing's stock price increase. Recent reports have mentioned that advancements in quantum computing technology are helping businesses gain new opportunities, which may have heightened market interest in Rigetti Computing.
Top Gainers in Pre-Market U.S. Stocks
Virpax Pharmaceuticals rose 38.15% in pre-market trading, with significantly increased trading volume. The rise in Virpax Pharmaceuticals' stock price is primarily driven by its recently announced positive research results. The company announced that its Probudur™ dosage range study achieved positive results, with the LBL100 dosage of up to 90 mg/kg showing good tolerance in Beagle dogs. This news may have boosted market confidence in the company's future development, leading to a substantial increase in stock price.
Bowen Acquisition rose 26.71% in pre-market trading, with significantly increased trading volume. The rise in Bowen Consulting Group's stock price may be related to its recent financial performance and strategic initiatives. The company signed a first amendment credit agreement on March 12, increasing its revolving credit facility from $100 million to $140 million, which may have enhanced market confidence in its financial stability. Additionally, the company's strong booking volume in the second half of 2024 and continued growth momentum in 2025 may have also driven the stock price increase. These factors combined may have led investors to hold an optimistic view of Bowen's future growth potential, resulting in a significant pre-market stock price increase. BofA Global Research reiterated a &#34;Buy&#34; rating on Bowen Consulting Group, believing that the company has a good ability to drive growth through mergers and acquisitions, and expects Bowen's stock price to rise in the long term as the construction market recovers. All five brokerages covering the stock have given a &#34;Buy&#34; or higher rating, with LSEG data showing a median target price of $34

RGTI

VRPX

BOWN

Rigetti Computing pre-market up 3.90%; Virpax Pharmaceuticals pre-market up 38.15%; Leishen Energy pre-market up 35.14%; Bowen Acquisition pre-market up 26.71%

Pre-market hot trades in US stocks: Rigetti Computing up 3.90% in pre-market